Kathryn E. Falberg - Jun 3, 2021 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role: Director
Signature: /s/ Carolyn Tang, Attorney-in-Fact
Stock symbol: RCUS
Transactions as of: Jun 3, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/7/2021, 04:34 PM
Previous filing: Jun 1, 2021
Next filing: Jun 9, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RCUS	Common Stock	Award	$0	+3K	+3.59%	$0.00	86.5K	Jun 3, 2021	Direct	F1, F2
holding	RCUS	Common Stock						102K	Jun 3, 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCUS	Stock Option (Right to Buy)	Award	$0	+14.1K		$0.00	14.1K	Jun 3, 2021	Common Stock	14.1K	$24.79	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of restricted stock units that vest 100% on the earlier of June 3, 2022 or the next annual meeting of the stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
F2	Includes 3,000 shares of restricted stock units (previously reported) that vested on June 3, 2021.
F3	The option will vest in full on the earlier of (i) 12 months following the date of grant or (ii) the date of the next annual stockholder meeting following the grant. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.